Dermatology World
Dermatologists will likely have to wait before the Biden administration turns its attention to health care issues impacting the specialty.
Remedies for warts abound, but high-quality studies are lacking.
Get familiar with the appeals process, your state’s laws, and what’s happening with reform efforts.
Academy experts explain what’s new in modifier 25 and E/M coding in 2021.
Amy Paller, MD, discusses the efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis.
DermWorld talks to David Fivenson, MD, about steps his practice has taken to reduce its carbon footprint.
One year after the first COVID-19 shutdown — how has teledermatology use changed?
Incident to: What is it, how is it utilized, and what are the pitfalls?
What can human and veterinary dermatologists learn from each other in the management and treatment of atopic dermatitis?
It survived for a decade, but will it survive another 10 years after COVID-19?
How dermatologists confront the impact of climate change on patients.
Physician editor Kathryn Schwarzenberger, MD, previews this month’s issue.
Members of DermWord’s Editorial Advisory Workgroup share exciting news from across the specialty.
Academy President Bruce Theirs, MD, bids farewell as his term comes to a close.
What resources does the Academy offer on how to correctly code with the new 2021 E/M coding guidelines?